The purification and chemical properties of thymosin, obtained from bovine thymus tissue, are described. The biological activity of the thymic hormone has been assessed by a newly developed rosette assay, which permits measurement of thymus-dependent lymphoid cells. Thymosin activity is associated with a physicochemically homogeneous protein of molecular weight 12,600. The hormonal activity is evident in in vitro incubation assay, after injection into adult thymectomized mice, and in prolonging survival of neonatally thymectomized mice and the reconstitution of their response to a skin allograft.
The extraction, partial purification, and assay of a thymic factor, which has been termed thymosin, from calf thymic tissue has been described by this laboratory (1) . Thymosin-containing fractions lowered the incidence, in neonatally thymectomized mice, of a wasting disease characterized by an atrophy of lymphoid tissue and high mortality (2) and a failure of development of cell-mediated immune responses, including the capacity of host cells to elicit a normal graftversus-host response (3) and to reject histoincompatible skin grafts (4) . In addition, thymosin administration to newborn normal mice accelerated the ontogenesis of cell-mediated immunity, as measured by the capacity of spleen cells from the treated animals to elicit a normal graft-versus-host response (5) and by the development of resistance to progressive tumor growth after inoculation with Moloney sarcoma virus (6) . The addition of thymosin preparations in vitro to discrete populations of lymphoid stem cells from bone marrow rapidly converted such cells into immunologically competent cells, as measured by a graft-versus-host assay (5) and by the appearance of cells with characteristics of T-cells (7) in the rosette bioassay.
In this preliminary communication, we describe the further purification and characterization of thymosin. We have isolated from thymus glands of calves a carbohydrate-and lipid-free homogeneous protein that, in preliminary assays, has several of the biological activities that we have reported for crude fractions (8, 9) . The purification and activity are based upon a modification of a new rosette-forming cell assay described recently (7) . A complete paper on the chemistry and additional properties of thymosin will be reported in a separate communication (Guha, A. et In the in vivo rosette assay for thymosin, the fractions to be assayed were injected intravenously into 60-day-old male CBA/J mice that had been thymectomized 1-2 weeks previously. 24 hr after injection, the animals were killed, their spleens were removed, and suspensions of cells were prepared and incubated in vitro for 90 min with azathioprine, followed by the subsequent steps described above.
Neonatal Thymectomy and Skin Allograft Procedures. Newborn CBA/Wh mice were thymectomized within 24 hr of birth. From 1 day after surgery, each animal received intraperitoneal injections of 2.5,gg of the fraction to be tested three times a week for the first 2 weeks, then 5.0 Mug daily by subcutaneous injection. At 6 weeks of age, surviving control and experimental mice were grafted (4) with full-thickness histoincompatible A/J skin, and graft survival was measured over the next 60 days.
RESULTS
The extraction and fractionation procedure used for the preparation of thymosin is diagramed in Fig. 1 The purification of thymosin described during fractionation is based upon the increase in activity per mg of protein by the rosette assay of Bach et al. (7) . This fractionation, which we presently use in our laboratory for the preparation of purified thymosin, includes several modifications from that described in previous publications (1, 8 from thymic tissue of other animals. Thus, we have demonstrated thymosin activity (Fraction 3) from mouse, rat, rabbit, guinea pig, hog, cow, steer, and human thymus (ref. 7 and unpublished studies).
The effect of various thymosin fractions administered in vivo on the reconstitution of sRF cells in a spleen population from adult thymectomized mice is shown in Table 1 . Previous studies by Bach et al. (12) have demonstrated that within 5 days after thymectomy, the number of azathioprine-sensitive sRF cells in a spleen is significantly decreased. The data in Table 1 show that 20,g of Fraction 7 administered intravencusly to adult, thymectomized mice 24 hr before death totally reconstituted the azathioprine sensitivity of spleen sRF cells, to the sensitivity observed with spleen cells from control, unoperated mice. Rechromatographed fraction 7A, as well as other calf tissue fractions, e.g., spleen, liver, and brain, are without significant activity. The effect of addition of thymosin Fractions 6 and 7 in vitro on the sensitivity to azathioprine of spontaneous rosette-forming cells in the spleens of adult thymectomized mice is shown in Table 3 . Similar studies are in progress with Fraction 7. The data in Table 3 show that the majority of thymosintreated mice (89%), in contrast to saline-treated (30%) or bovine-serum albumin-treated controls (35%), are alive 8 weeks after thymectomy, and have the capacity to reject their skin allografts in a manner comparable to normal mice.
DISCUSSION
A homogeneous protein preparation with thymosin activity has been prepared with the aid of a new rosette assay developed by Bach et al. (7) . The purified thymosin preparation does not contain lipid or carbohydrate. It has been established by Bach and Dardenne (13) that the majority of spontaneous rosette-forming cells in spleens of normal, unsensitized mice are thymic-dependent. Evaluation of thymic dependency has been based upon the extreme sensitivity of sRF cells from nonimmunized animals to azathioprine, antilymphocyte serum, and antitheta serum. Spleen cells from neonatally thymectomized mice, from "nude mice" that congenitally lack a thymus, or from adult, thymectomized, irradiated, and bone marrow reconstituted mice are much less sensitive to azathioprine (13) . Recently, Bach et al. (12) have demonstrated that within 7 days after thyme-tomy of adult mice, the population of cells that are sensitive to azathioprine, antilymphocyte serum, and antitheta serum is significantly reduced in the spleen.
The studies cited above appear in contrast to the majority of reports that thymus-dependent cells are not markedly affected immediately after adult thymectomy (14) . Newer data indicate, however, that subpopulations of T-cells exist that apparently require the presence of the thymus gland. These cell types give rise to azathioprine-sensitive cells, which may be similar to the population of T-cell precursors designated as "T1" by Raff and Cantor (15) . Ti-cells are characterized by being present in greater numbers in spleen and thymus than in lymph nodes, blood, or thoracic duct lymph, are relatively insensitive to antilymphocyte serum in vivo, and are more sensitive in vitro to lysis by antitheta serum and complement (15) .
Our observation (7) that thymosin can restore the population of azathioprine-sensitive cells when added in vitro to cell suspensions prepared from spleens of adult, thymectomized mice suggests the presence of a thymosin-sensitive thymusdependent cell. This cell is present in spleen in adequate numbers, and requires only an endocrine influence of the thymus gland to be converted to the more mature thymosinactivated cell. We have reported (7) that this thymosin-sensitive cell is also present in bone marrow, as evidenced by its conversion to a thymosin activated cell (azathioprine sensitive) after incubation in vitro with thymosin. We shall discuss elsewhere, in detail, a possible sequence of events leading to the maturation of immunologically competent cells (Goldstein, A. L. & White, A., in preparation).
The availability of thymosin in purified form makes possible a detailed study of its mode of action, and the development of a radioimmunoassay to measure its concentration in biological fluids. This approach should facilitate delineation of the endocrine functions of the thymus gland in the ontogenesis and maintenance of the immune system, and perhaps will provide a better understanding of the role of the thymus in the development of resistance to disease.
